We're excited to join the LinkedIn community! Follow us for industry news, expert advice, and exclusive updates from our team. We can't wait to engage with all of you. #Enkrisi for more information, subscribe to: https://enkrisi.com/ Introducing ENKRISI – the leading consulting group helping organizations comply with drug regulations through a comprehensive drug development model incorporating augmented intelligence (AI) and data analytics. Our team of industry experts is equipped to help both emerging biotechs and established pharmaceuticals understand how to use AI and machine learning to stay on top of rapidly changing regulatory requirements. We're here to help navigate the complex world of compliance more manageable than ever!
Enkrisi
Technology, Information and Internet
Philadelphia, , PA 1,766 followers
Reimagining Regulatory Pathways
About us
ENKRISI - (THE NEW BETTER NORMAL) We provide a capable and dynamic consultancy that stands out from the rest regarding drug development and regulatory affairs within the pharmaceutical industry. Through leveraging data, apps, and platforms with Augmented Intelligence (IA), Enkrisi offers clients an impressive experience backed by experienced human advisors. With their expertise, you can ensure your drugs are optimized for success and make an impact in the life sciences universe. The Regulatory Intelligence of Tomorrow! Regulatory Intelligence is essential for all organizations to stay ahead of the ever-changing regulatory landscape. A modernized approach to regulatory affairs and the development of new technologies and tools for monitoring emerging requirements can help maximize efficiency, reduce licensing timelines, and ensure the accuracy of product details. By investing in advanced regulatory intelligence systems, companies can stay current with impending regulations and remain competitive in their respective industries. Introducing ENKRISI – the leading consulting group helping organizations comply with drug regulations through a comprehensive drug development model incorporating augmented intelligence (AI) and data analytics. Our team of industry experts is equipped to help both emerging biotechs and established pharmaceuticals understand how to use AI and machine learning to stay on top of rapidly changing regulatory requirements. We're here to help navigate the complex world of compliance more manageable than ever! Our Reimagining Regulatory Pathways Services can help you design and implement best practices to streamline your operations and ensure you stay in line with current legislation. We provide a range of services covering technical and strategic aspects of regulatory drug development. Our team can assist with developing an overall strategy that accounts for all potential risks while still being able to meet your objectives.
- Website
-
www.enkrisi.com
External link for Enkrisi
- Industry
- Technology, Information and Internet
- Company size
- 11-50 employees
- Headquarters
- Philadelphia, , PA
- Type
- Privately Held
Locations
-
Primary
Get directions
Philadelphia, , PA 19147, US
Updates
-
🌟 Ready to conquer CMC hurdles? Join Enkrisi's journey to success! #ThePathfinder #BiotechGrowth @enkrisi @FDA #CMC
-
Navigate CMC challenges with expert insights. Learn how to enhance your regulatory submissions! #RegulatoryCMC #IND @enkrisi
Master IND, NDA & BLA Submissions with Enkrisi’s Expert CMC Guidance!
web-extract.constantcontact.com
-
🚀 Get ready for CMC success this Fall! Subscribe for insights & tips! #RegulatoryAffairs #CMCDrugDev https://conta.cc/3BCz8BF
Unlock the Blueprint for CMC Success, Master Your NDA Journey? + New Podcast!
web-extract.constantcontact.com
-
Our podcast, The VirtualPharm, is here to keep you in the loop! Tune in! #RegulatoryInsights #CMC
New CMC Podcast! + The First-Ever Hybrid Model Consultancy
web-extract.constantcontact.com
-
Unlock your drug development potential! Get a free assessment today. #RegulatorySuccess #DrugDevelopment @enkrisi
New from Ed Narke — Navigating Regulatory CMC Success
web-extract.constantcontact.com
-
Ready to conquer CMC challenges? Join Enkrisi's journey to success! #Pathfinder #Biotech
Comparability Protocol Guidance, New CMC Podcast, and the Story Behind Gravity Discovery
web-extract.constantcontact.com
-
🎧 Get ready! The VirtualPharm podcast is dropping soon! Don’t sleep on it! Check out the preveiw now. #CMC #PodcastVibes Spotify - https://lnkd.in/e7xM3TYu Amazon Music - https://lnkd.in/eY33jhZA YouTube - https://lnkd.in/eEmMfdQz And coming to iHeart radio and Apple Podcasts soon!
-
-
🚀 Introducing The VirtualPharm: your essential podcast for navigating Regulatory CMC. Join us as we explore complex topics, from FDA regulations to compliance challenges. Subscribe now on YouTube, https://lnkd.in/gVsqzqxP and on Spotify, or Apple Podcasts on September 30th, and empower your biotech journey with expert insights. Don’t miss out! #VirtualPharm #RegulatoryIntelligence #Biotech #CMC #Podcast https://conta.cc/3TK0pIt
🎙️ New Podcast Alert: The VirtualPharm - Bringing Regulatory CMC to Life!
web-extract.constantcontact.com
-
Determining the appropriate number of virus inactivation/removal steps for your product is crucial and depends on several factors, including the nature of your product and the manufacturing process. This Q&A provides insights into how to approach viral clearance to meet regulatory expectations effectively. @edwardnarke #ViralClearance
How many virus inactivation/removal steps do we need to satisfy Health Authorities' Expectations?
Enkrisi on LinkedIn